Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00344136 · ClinicalTrials.gov registry record
Identifying Genes That May Increase the Risk for Heart Disease in African Americans
A clinical trial of Heart Diseases, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 5,302
- Enrollment target
- 1
- Study location
NCT00344136 is a study of Heart Diseases that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 5,302 participants, roughly in line with the 5,470-participant average among 85 other Heart Diseases trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT00344136, a study of Heart Diseases, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 5,302 participants
- Enrollment target
- 1
- Study location
Study Summary
Heart disease and stroke disproportionately affect African Americans in the United States. These conditions are likely caused by both environmental and genetic factors. This study will attempt to identify specific genes of African and European ancestral origins that may influence the development of heart disease in African Americans.
Conditions Studied
Study Locations (1)
Mississippi
- University of Mississippi School of Medicine - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,302 participants |
| Start Date | 2000-09 |
| Est. Completion | 2004-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00344136
The ClinicalTrials.gov registry entry for NCT00344136 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,302 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 5,470-participant average among 85 other Heart Diseases trials with a reported enrollment target. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT00344136 reports 1 study location spanning 1 distinct geographic area - top geographies include Mississippi.
Frequently Asked Questions
What is clinical trial NCT00344136 about?
NCT00344136 is a clinical study titled "Identifying Genes That May Increase the Risk for Heart Disease in African Americans". Heart disease and stroke disproportionately affect African Americans in the United States. These conditions are likely caused by both environmental and genetic factors. This study will attempt to identify specific genes of African and European ancestral origins that may influence the development of ...
What is the current status of trial NCT00344136?
This trial is currently completed. The enrollment target is 5,302 participants. The study started on 2000-09. Estimated completion is 2004-03.
What conditions does trial NCT00344136 study?
This clinical trial studies the following conditions: Heart Diseases.
Who is sponsoring clinical trial NCT00344136?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00344136 being conducted?
This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Angiography and Electrogram Guided Bachmann Bundle Pacing
RECRUITING · NA
-
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
RECRUITING · NA
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
Lumason® Infusion vs. Bolus Administrations
RECRUITING · Phase 3
-
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.